Begin main content

Empagliflozin

Last Updated: March 25, 2015
Result type: Reports
Project Number: SR0427-000
Product Line: Common Drug Review

Generic Name: Empagliflozin

Brand Name: Jardiance

Manufacturer: Boehringer Ingelheim (Canada) Ltd.

Indications: Diabetes mellitus (Type 2)

Submission Type: Pre-NOC

Project Status: Active

Date Recommendation Issued: October 15, 2015

Recommendation Type: List with clinical criteria and/or conditions

Tags

diabetes mellitus, type 2, diabetes